Sun Pharmaceutical (SUNPHARMA) — Board Meeting

📢 Key Event
Proposal to reclassify three related parties from Promoter Group to Public category via shareholder vote.

🔄 What Changed
Promoter holding down from 54.48% to 52.68%; Public holding up from 45.52% to 47.32%; Board approved on 22 May 2026; Stock exchanges gave NOC on 6 August 2026.

🔮 What's Next
Voting opens 28 August 2026, closes 26 September 2026, results announced on or before 29 September 2026.

💡 Investor Takeaway
This reclassification adjusts shareholder categories without changing control or ownership, potentially affecting index inclusion and institutional perception.

Sun Pharmaceutical Industries Limited announced a shareholder postal ballot to reclassify three related parties — Sudhir Valia, Raksha Valia, and Krishna Valia — from the Promoter Group to the Public category. The proposal seeks shareholder approval via an ordinary resolution, with voting opening on 28 August 2026 and closing on 26 September 2026. The reclassification will reduce promoter holding from 54.48% to 52.68% and increase public holding from 45.52% to 47.32%, without altering control or shareholding structure. The Board approved the move on 22 May 2026 after receiving no-objection letters from NSE and BSE on 6 August 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹4,69,309.92 Cr P/E: 38.8 ROE: 14.6% ROCE: 18.7% Div Yield: 0.82%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How will the reclassification affect SUNPHARMA's inclusion in promoter-heavy indices?" "What is the expected impact on share price volatility post-reclassification?" "How does the new public shareholding percentage compare to peer companies?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 25 August 2026

EPL EPL Limited Annual Report AMANTA Amanta Healthcare Limited Annual Report ZEEL Zee Entertainment Enterprises Limited Annual Report FINKURVE Finkurve Financial Services Limited Corporate Action EPL EPL Limited Annual Report ARVIND Arvind Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SUNPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd